Abstract:Objective:To investigate the changing characteristics of the immunocytes after human immunodeficiency virus (HIV) infection and the dynamic changing patterns of different disease stages.Methods:Lymphocyte subsets of 173 patients with HIV/acquired immunodeficiency syndrome (AIDS) hospitalized in Department of Infectious Diseases, Zhongnan Hospital of Wuhan University from August 17th, 2021 to September 14th, 2022 (research group) were analyzed by flow cytometry, and were compared with 1 086 healthy individuals (control group). AIDS was staged according to the CD4+ T lymphocyte count; The lymphocyte subset classification counts of patients with HIV/AIDS at different AIDS stages were compared. The absolute counts of different types of lymphocytes in the measurement data were normally distributed, expressed by ±s, and the mean values of all types of lymphocytes between patients with HIV/AIDS and control group were compared by two independent samples t-tests.Results:The absolute counts of T lymphocytes, B lymphocytes and NK cells of patient in research group were (907 ± 105) cells/μl, (128 ± 25) cells/μl and (176 ± 16) cells/μl, respectively, which were significantly lower than those in control group (t = 8.508, P < 0.001; t = 8.265, P < 0.001; t = 18.552, P < 0.001). CD4+CD28+ cells and CD8+CD28+ cells of patient in research group were (123 ± 25) cells/μl and (245 ± 98) cells/μl, which were both significantly lower than those of control group (t = 28.522, P < 0.001; t = 5.820, P < 0.001). CD3+CD8+HLA-DR+ cell counts and percentages of patient of research group were (476 ± 129) cells/μl and 73.68%, respectively, which were both higher than those of control group (t = 8.482, P < 0.001; t = 34.651, P < 0.001). The absolute counts of na?ve and memory CD4+ T cells of patient of research group were (76 ± 9) cells/μl and (152 ± 12) cells/μl, respectively, which were significantly lower than those of control group (t = 19.823, P < 0.001; t = 20.815, P < 0.001). As the disease progressed, the absolute counts of CD4+CD28+ cells and CD8+CD28+cells gradually decreased from (540.77 ± 165.54) cells/μl and (452.57 ± 135.65) cells/μl to (13.56 ± 33.63) cells/μl and (102.96 ± 30.47) cells/μl, and the percentages of CD3+CD8+ HLA-DR+ cells increased from (36.00 ± 17.79)% to (58.29 ± 13.27)% of patients in research group.Conclusions:Abnormalities in lymphocyte count and function, as well as abnormal activation of the immune system are common in patients with HIV/AIDS. In late stage of AIDS, impaired lymphocyte function and abnormal immune activation are more significant.

Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection

Histopathological study of cutaneous manifestations in HIV and AIDS patients

[Immune Activation in AIDS Related Kaposi's Sarcoma].

Frequency, pattern, and extent of skin diseases in relation to CD4+ cell count among adults with human immunodeficiency virus infection or acquired immunodeficiency syndrome in Osogbo, southwestern Nigeria

Prevalence of Skin Diseases in Children with Human Immunodeficiency Syndrome Infection in Paediatric HIV Clinic of A Tertiary Hospital in Nigeria.

Facial skin findings are indicators of human immunodeficiency virus infection and acquired immune deficiency syndrome: a retrospective study

Cutaneous findings associated with HIV disease including AIDS: experience from Sub Saharan Africa.

Incidence and prognostic significance of skin disease in patients with HIV/AIDS: a 5-year observational study.

Distinct serum cytokines in AIDS-related skin diseases.

Analysis of the expression characteristics and clinical value of immune function indicators in patients with human immunodeficiency virus infection

Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients

Dermatological Opportunistic Infections in HIV Seropositive Patients: An Observational Study

Application of refined lymphocyte subsets detection on patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome

Is human immunodeficiency virus (HIV) stage an independent risk factor for altering the periodontal status of HIV-positive patients? A South African study

Evaluation of cellular immune responses in HIV-infected people and AIDS patients

Hiv/aids – Research and Palliative Care Dovepress Serum Selenium and Skin Diseases among Nigerians with Human Immunodeficiency Virus/ Acquired Immune Deficiency Syndrome

Expression of CD127 of T lymphocytes in peripheral blood of patients with HIV-1/AIDS and its clinical significance

Skin disease in homosexual patients with Acquired Immune Deficiency Syndrome (AIDS) and lesser forms of human T cell Leukaemia Virus (HTLV III) disease

Oral manifestations of HIV: Can they be an indicator of disease severity? (A systematic review)

Study of Inflammatory Biomarkers in Treatment-Naive HIV Patients and Their Correlation With Clusters of Differentiation 4 (CD4) Count

Skin Diseases in the Era of Highly Active Antiretroviral Therapy: A Retrospective Study of 534 Patients